About us - Newsroom - Product news

Product news

View 10 | 50 | 100 entries/page
Showing 1 - 10 of 24

Neural cell specific primary antibodies

Antibodies suitable for ICC or IHC staining of astrocytes, oligodendrocytes, microglia, neuronal stem cells and neurons.


October 1, 2017

StraightFrom LRSC MicroBead Kits, human

Everything you need for the positive isolation of either CD4+, CD8+, CD19+, CD56+ or CD14+ cells directly from LRS cones.


October 1, 2017

21 CFR Part 11 enabled MACSQuantify Software V2.11

Set up your flow cytometry measurements and analyses in compliance with 21 CFR Part 11.


September 1, 2017

New TIL MicroBeads

Directly isolate either CD45+, CD4+, CD8+ or CD4+ and CD8+ from dissociated mouse tumor tissues.


September 1, 2017

NK Cell Isolation Kit, mouse

Isolate untouched NK cells for in vitro and in vivo applications.


September 1, 2017

StemMACS Trilineage Differentiation Kit, human

Assess the differentiation potential of human pluripotent stem cells with our new kit.


September 1, 2017

New: MACSprep PBMC Isolation Kit, human from Miltenyi Biotec

Fast and convenient isolation of untouched PBMCs


June 14, 2017

NK MACS® Medium, human

Cell culture medium for optimized expansion of a human NK cell culture with fully functional cells and minimal T cell growth.


May 2, 2017

New MACS® antibody format

Optimize your multi-color experiments with our new antibodies in a concentrated format of only 2 µL per test. Check all advantages here.


May 1, 2017

24-well and Single-well Deep Well Plates

Sterile plates for the collection of large sample volumes or up to 24 samples in parallel using the MultiMACS™ Cell24 Separator.


April 6, 2017

View 10 | 50 | 100 entries/page
Showing 1 - 10 of 24

Customer login

Go

Forgot password?
Register for account

0 Shopping cart

Contact

Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
macs@miltenyibiotec.com
Contact overview

Product finder

Antibody panel builder

Toolbox

Loading...
Media contact

Media contact

Change country

Please select your country to continue